Literature Distribution Month
Together, through prayer and sharing literature, God can use His church to share hope with 50,000 souls.
Every year, the global church produces a small easy-to-read book that addresses areas of concern such as spiritual, family, health or emotional need. Each year, on a designated impact day, church members are encouraged to participate in a massive global literature distribution in their communities. The main purpose of the impact day is to bring hope to the community.
This May, for the first time in recent history, every conference within Australia and New Zealand will unite in this exciting global mission to share Hope For Troubled Times, written by Mark Finley. The mission book was written with the COVID-19 pandemic and its aftermath in mind, concentrating on providing spiritual answers to people’s questions about the future.
This year, your conference can choose between participating in the Impact Day on May 15 or Impact Month—distributing literature over the entire month of May.
2020 may be over, but the effects of COVID-19 continue to linger. The future seems confusing and uncertain and is leaving people feeling anxious and fearful. 50,000 copies of Hope For Troubled Times have been printed. Join the movement this May to share the hope of Jesus’ soon return with your community.
The Australian and New Zealand Conferences together, have ordered over 50,000 copies of the book, and over 100,000 tracts to share the hope in Jesus. Thank you for your support of this mission project. The book is planned to be delivered to the Conferences by the end of April ready for distribution in the month of May – specifically for the Impact Day on Sabbath May 15th.
The production of this book and tract has been subsidised with funding from the Literature Ministry Committee to support the church’s focus on providing resources for church members, churches and church entities to share in their communities.
*Please check with your Pastor for Conference advice regarding organised activities during COVID-19.